Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E

Abstract Background Several lines of evidence suggest that high-density lipoprotein (HDL) reduces Alzheimer’s disease (AD) risk by decreasing vascular beta-amyloid (Aβ) deposition and inflammation, however, the mechanisms by which HDL improve cerebrovascular functions relevant to AD remain poorly un...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Jerome Robert, Emily B. Button, Emma M. Martin, Luke McAlary, Zoe Gidden, Megan Gilmour, Guilaine Boyce, Tara M. Caffrey, Andrew Agbay, Amanda Clark, Judith M. Silverman, Neil R. Cashman, Cheryl L. Wellington
التنسيق: Artigo
اللغة:Inglês
منشور في: BMC 2020-03-01
سلاسل:Molecular Neurodegeneration
الموضوعات:
Alzheimer’s disease
Cerebrovasculature
High-density lipoprotein (HDL)
Cerebral amyloid angiopathy (CAA)
Endothelial inflammation
Apolipoprotein (apo)E
الوصول للمادة أونلاين:http://link.springer.com/article/10.1186/s13024-020-00366-8
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة